Second Quarter of Fiscal 2025 Continuing Operations Highlights* Net sales were $146 million, a 5.1% increase compared to the prior year, with a 5.0% increase in organic sales.1Operating profit margin ...
We learned to find each other through signs—through violets exchanged in secret, through rings on middle fingers, through a well-placed handkerchief peeking out of a pocket.
My monthly update and commentary on the top dividend stock picks from Barron's Sustainable companies list, March 2025 edition ...
Discover key projections, inversion risks, and future challenges in U.S. bonds. Click for more on our simulation.
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results